8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General

Effects of Nonthermal Radiofrequency Stimulation on Neuronal Activity and Neural Circuit in Mice

Bioeffects Seen

Hao Y, Liu W, Liu Y, Liu Y, Xu Z, Ye Y, Zhou H, Deng H, Zuo H, Yang H, Li Y · 2023

Share:

Nonthermal radiofrequency stimulation can modulate neuronal activity and neural circuit function at non-heating exposure levels, potentially affecting cognitive performance through dopaminergic and glutamatergic mechanisms.

Plain English Summary

Summary written for general audiences

This 2023 study investigated nonthermal effects of 2856-MHz radiofrequency radiation (RFR) on the mouse nervous system. The researchers found that RFR exposure within thermal noise limits induced spatial memory impairment through reduced dopamine release in the hippocampus and enhanced glutamate-mediated neuronal calcium activity, with effects reversing after RFR termination.

Why This Matters

The study attempts to distinguish nonthermal from thermal RFR effects by maintaining temperature changes below 1°C during exposure. The findings suggest biological mechanisms independent of heating, though the translational relevance to human exposure conditions and the generalizability of rodent memory models require consideration.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Hao Y, Liu W, Liu Y, Liu Y, Xu Z, Ye Y, Zhou H, Deng H, Zuo H, Yang H, Li Y (2023). Effects of Nonthermal Radiofrequency Stimulation on Neuronal Activity and Neural Circuit in Mice.
Show BibTeX
@article{hao_y_liu_w_liu_y_liu_y_xu_z_ye_y_zhou_h_deng_h_zuo_h_yang_h_li_y_ce3258,
  author = {Hao Y and Liu W and Liu Y and Liu Y and Xu Z and Ye Y and Zhou H and Deng H and Zuo H and Yang H and Li Y},
  title = {Effects of Nonthermal Radiofrequency Stimulation on Neuronal Activity and Neural Circuit in Mice},
  year = {2023},
  doi = {10.1016/j.lanwpc.2023.100694},
  
}
DOI: 10.1016/j.lanwpc.2023.100694PubMed: 36755196

Quick Questions About This Study

This appears to be a database categorization error. The study examined Paxlovid antiviral medication effects on hospitalized COVID-19 patients, with no electromagnetic field exposure involved. Proper research curation requires distinguishing pharmaceutical studies from EMF exposure research.
No, Paxlovid is an oral antiviral medication containing nirmatrelvir and ritonavir. This study examined drug efficacy in COVID-19 patients and has no connection to electromagnetic field exposure or wireless technology health effects research.
Among 264 hospitalized COVID-19 patients with severe health conditions, Paxlovid treatment showed no significant reduction in 28-day mortality (3.8% vs 6.1%) or faster viral clearance compared to standard treatment alone in this Shanghai-based trial.
Pharmaceutical research examines chemical drug effects on biological systems, while EMF studies investigate electromagnetic field exposure impacts. This Paxlovid study used standard medical endpoints like mortality and viral clearance, not EMF-specific biomarkers or exposure measurements.
Misclassified studies like this pharmaceutical trial reduce database reliability and can lead to incorrect conclusions about EMF health effects. Proper research requires distinguishing between actual electromagnetic field exposure studies and unrelated medical research topics.